ANTARA CAPITAL LP – Inhibikase Therapeutics, Inc. Transaction History
ANTARA CAPITAL LP portfolio value:
$0
portfolio value
ANTARA CAPITAL LP quarter portfolio value change:
+22.54%
quarter
Inhibikase Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -403K shares | -299K | $0.91 | 0 |
| Q2 2022 | share | Increase | +33.00% | 100K shares | -149K | $0.74 | 403K |
| Q1 2022 | share | 0.00% | 0 shares | 3K | $1.48 | 303K | |
| Q4 2021 | share | 0.00% | 0 shares | -131K | $1.5 | 303K | |
| Q3 2021 | share | Increase | +21.20% | 53K shares | -124K | $1.9 | 303K |
| Q2 2021 | share | Increase | 0.00% | 250K shares | 700K | $2.8 | 250K |